Jeremy G. Chadwick

Insider Reports History

Entity
Individual
Location
C/O Kymera Therapeutics, Inc., 200 Arsenal Yards Blvd., Suite 230, Watertown, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy G. Chadwick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kymera Therapeutics, Inc. Chief Operating Officer Common Stock 67.8K $2.1M $31.00 Mar 3, 2025 Direct
Kymera Therapeutics, Inc. Chief Operating Officer Stock Option (Right to Buy) 50K Mar 3, 2025 Direct

Insider Reports Filed by Jeremy G. Chadwick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KYMR Kymera Therapeutics, Inc. Mar 3, 2025 4 -$42.1K 4 Mar 3, 2025 Chief Operating Officer
KYMR Kymera Therapeutics, Inc. May 23, 2024 1 -$90.1K 4 May 23, 2024 Chief Operating Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 4, 2024 Chief Operating Officer
KYMR Kymera Therapeutics, Inc. May 22, 2023 2 $0 4 May 22, 2023 Chief Operating Officer
KYMR Kymera Therapeutics, Inc. May 22, 2023 0 $0 3 May 22, 2023 Chief Operating Officer